Your browser doesn't support javascript.
loading
Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion.
Argenziano, Giuseppe; Fargnoli, Maria Concetta; Fantini, Fabrizio; Gattoni, Massimo; Gualdi, Giulio; Pastore, Francesco; Pellacani, Giovanni; Quaglino, Pietro; Queirolo, Paola; Troiani, Teresa.
Affiliation
  • Argenziano G; Dermatology Unit, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Fargnoli MC; Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, Coppito 2, 67100 L'Aquila, Italy.
  • Fantini F; Dermatology Unit, 'A. Manzoni' Hospital, Lecco, Italy.
  • Gattoni M; Dermatologia, Ospedale S. Andrea, Vercelli, Italy.
  • Gualdi G; Dermatologic Clinic, Department of Medicine and Aging Science, University G. D'Annunzio Chieti-Pescara, Italy.
  • Pastore F; Radiation Oncology, Emicenter, Naples, Italy.
  • Pellacani G; Dermatology Clinic, La Sapienza, University of Rome, Rome, Italy.
  • Quaglino P; Clinica Dermatologica, AOU Città della Salute e della Scienza, Università degli Studi di Torino, Torino, Italy.
  • Queirolo P; Melanoma, Sarcoma and Rare Tumors Oncology Department, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Troiani T; Oncology Unit, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Ther Adv Med Oncol ; 14: 17588359211066272, 2022.
Article de En | MEDLINE | ID: mdl-35035534
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline / Prognostic_studies Aspects: Patient_preference Langue: En Journal: Ther Adv Med Oncol Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline / Prognostic_studies Aspects: Patient_preference Langue: En Journal: Ther Adv Med Oncol Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni